Delivery of full dose CHOP chemotherapy to elderly patients with aggressive non-Hodgkin's lymphoma without G-CSF support

Leukemia and Lymphoma

Volumn 35, Issue 1-2, 1999, Pages 119-127

  Campbell, C ^a   Sawka, C ^a,c   Franssen, E ^b   Berinstein, N L ^a,b,c  

^a Division of Haematology/Oncology   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; VINCRISTINE;

AGED; ANEMIA; ANOREXIA; ARTICLE; BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; DIARRHEA; DYSPEPSIA; FATIGUE; FEBRILE NEUTROPENIA; HUMAN; LUNG TOXICITY; MAJOR CLINICAL STUDY; NAUSEA; NONHODGKIN LYMPHOMA; PAIN; PRIORITY JOURNAL; STOMATITIS;

EID: 0032828820     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145711     Document Type: Article

References (36)

1. Levin, P. H., and Hoover, R. (1992) The emerging epidemic of non-Hodgkin's lymphoma: Current knowledge regarding etiological factors. Cancer Epidemiol Biomark Prev, 1, 515-517.
2. Devessa, S. S., and Fears, T. (1992) Non-Hodgkin's lymphoma time trends: United States and International Data. Cancer Res, 52 (suppl), 5432S-5440S.
3. Fisher, R. I., Gaynor, E. R., Dahlberg, S., et al. (1994) A phase III comparison of CHOP vs m-BACOD vs ProM-ACE-CytoBOM vs MACOP-B in patients with intermediate or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067). Annals of Oncology 5, S91-S95.
4. d'Amore, F., Brincker, H., Christensen, B. E., et al. (1992) Non-Hodgkin's lymphoma in the elderly. Annals of Oncology, 3, 379-386.
5. Shipp, M. A. e. a. (1993) A Predictive Model for Aggressive non-Hodgkin's Lymphoma - The International non-Hodgkin's Lymphoma Prognostic Factor Project. New England Journal of Medicine, 329, 987-994.
6. Ansell, S. M., Falkson, G., van der Merwe, R., et al. (1992) Chronological age is a multifactorial prognostic variable in patients with non-Hodgkin's lymphoma. Annals of Oncology, 3, 45-50.
7. Orlandi, E., Lazzarino, M., Brusamolino, E., et al. (1991) Non-Hodgkin's lymphoma in the elderly: the impact of advanced age on therapeutic options and clinical results. Haematologica, 76, 204-208.
8. Vose, J. M., Armitage, J. O., and Weisenburger, D. D. e. a. (1988) The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology, 6, 1838-1844.
9. Armitage, J. O., and Potter, J. F. (1984) Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly. L Am Geriatr Soc. 32, 269-273.
10. Tirelli, U., Zagonel, V., Serraino, D., et al. (1988) Non-Hodgkin's lymphoma in 137 patients aged 70 years or older: a retrospective European organization for research and treatment of cancer lymphoma group study. Journal of Clinical Oncology. 6, 1708-1713.
11. Meyer, R. M., Browman, G. P., Samosh, M. L., et al. (1995) Randomized phase II comparison of standard CHOP with weekly chop in elderly patients with non-Hodgkin's lymphoma. Journal of Clinical Oncology, 13, 2386-2393.
12. Sonneveld, P., Hop, W., Mulder, A. H., et al. (1994) Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Seminars in Hematology, 31, 9-12.
13. Dixon, D. O., and Neilan, B., et al (1986) Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma. Journal of Clinical Oncology, 4, 295-305.
14. Ansell, S. M., and Falkson, G. (1993) A phase II trial of a chemotherapy combination in elderly patients with aggressive lymphoma. Annals of Oncology, 4, 172-175.
15. Bertini, M., Freilone, R., Vitolo, U., et al. (1994) P-VEBEC: A new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL). Annals of Oncology, 5, 895-900.
16. Bessell, E. M., Coutts, A., Fletcher, J., et al. (1994) Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate or high-grade histology. European Journal of Cancer, 30A, 1337-1341.
17. Caracciolo, F., Petrini, M., Capochiani, E., et al. (1994) Alternate chemotherapy regimen (P-VABEC) for intermendiate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly. Hematological Oncology. 12, 185-192.
18. Goss, P. E., Burkes, R., Rudinskas, L., et al. (1994) Prednisone, oral etoposide and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report. Seminars in Hematology, 31, 23-29.
19. Kitamura, K., and Fumimaro, T. (1990) THP-COP Therapy for non-Hodgkin's lymphoma in the elderly. Am J Clin Oncol, 13(suppl 1), S15-S19.
20. Liang, R., Todd, D., Chan, T K., et al. (1993) COPP chemotherapy for elderly patients with intermediate and high grade non-Hodgkin's lymphoma. Hematological Oncology, 11, 43-50.
21. Martelli, M., Guglielmi, C, and Coluzzi, S. e. a. (1993) A prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology, 11, 2362-2369.
22. McMaster, M. L., Johnson, D. H., and Greer, J. P. e. a. (1991) A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma. Cancer, 67, 1487-1492.
23. Novitzky, N., King, H. S., Johnson, C., et al. (1995) Treatment of agressive non-Hodgkin's lymphoma in the elderly. American Journal of Hematology, 49, 103-108.
24. O'Reilly, S. E., Klimo, P., and Connors, J. M. (1991) Low-dose ACOP-B and VABE: Weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma. Journal of Clinical Oncology, 9, 741-747.
25. O'Reilly, S. E., Connors, J. M., and Howdle, S. e. a. (1993) In search of an optimal regiman for elderly patients with advanced stage diffuse large cell lymphoma: Results of a phase II study of P/DOCE chemotherapy. Journal of Clinical Oncology, 11, 2250-2257.
26. Salvagno, L., Contu, A., Bianco, A., et al. (1992) A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma. Annals of Oncology, 3, 833-837.
27. Sonneveld, P., and J.J., M. (1990) Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen. Br J Cancer, 62, 105-108.
28. Tigaud, J.-D., Demolombe, S., Bastion, Y., et al. (1991) Ifosfamide continuous infusion plus etoposide in the treatment of elderly patients with aggressive lymphoma: a phase II study. Hematological Oncology, 9, 225-233.
29. Tirelli, U., Carbone, A., Zagonel, V., et al. (1987) Non-Hodgkin's lymphomas in the elderly: Prospective studies with specifically devised chemotherapy regimens in 66 patients. Eur J Cancer Clin Oncol, 23, 535-540.
30. Tirelli, U., Zagonel, V., and Serraino, S. R. e. a. (1992) A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavourable non-Hodgkin's lymphoma. Journal of Clinical Oncology, 10, 228-236.
31. Zinzani, P. L., Bendandi, M., Gherlinzoni, F., et al. (1993) VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly. Haematologica, 78, 378-382.
32. Hryniuk, W. A. 1988. The importance of dose intensity in outcome of chemotherapy. In Important advances in oncology 1988.V. J DeVita, S. Hellman, and S. A. Rosenberg, eds. Lippincott, Philadelphia, p. 121-141.
33. Kaplan, E. L., and Meier, P. (1958) Nonparametric estimation from incomplete observations. J. Amer. Stat. Assoc., 53, 457-481.
34. Epelbaum, R., Haim, N., Leviov, M., et al. (1995) Full dose CHOP chemotherapy in elderly patients with non-Hodgkin's lymphoma. Acta Oncologica, 34, 87-91.
35. Grogan, L., Corbally, N., Dervan, P. A., et al. (1994) Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose Adriamycin-based regimens*. Annals of Oncology, 5(Suppl. 2), S47-S51.
36. Golde DW, Neidhart JA, Scadden DT, et al. The rational use of hematopoietic growth factors. Proc Am Soc Hem 37: 112-118, 1995.